Biosenta Statistics

Total Valuation

Biosenta has a market cap or net worth of CAD 2.87 million. The enterprise value is 9.82 million.

Market Cap	2.87M
Enterprise Value	9.82M

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Biosenta has 35.94 million shares outstanding. The number of shares has increased by 7.41% in one year.

Current Share Class	35.94M
Shares Outstanding	35.94M
Shares Change (YoY)	+7.41%
Shares Change (QoQ)	-3.13%
Owned by Insiders (%)	14.46%
Owned by Institutions (%)	n/a
Float	30.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3,058.40
PB Ratio	-0.27
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.90
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.88

Financial Position

The company has a current ratio of 0.01

Current Ratio	0.01
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-15.49
Interest Coverage	-1.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-593.52%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	11.98%
Weighted Average Cost of Capital (WACC)	10.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	0.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.83% in the last 52 weeks. The beta is 0.04, so Biosenta's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	-44.83%
50-Day Moving Average	0.10
200-Day Moving Average	0.14
Relative Strength Index (RSI)	42.21
Average Volume (20 Days)	8,553

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biosenta had revenue of CAD 940 and -2.51 million in losses. Loss per share was -0.08.

Revenue	940
Gross Profit	399
Operating Income	-1.27M
Pretax Income	-2.51M
Net Income	-2.51M
EBITDA	-1.26M
EBIT	-1.27M
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

The company has 7,813 in cash and 6.95 million in debt, with a net cash position of -6.94 million or -0.19 per share.

Cash & Cash Equivalents	7,813
Total Debt	6.95M
Net Cash	-6.94M
Net Cash Per Share	-0.19
Equity (Book Value)	-10.62M
Book Value Per Share	-0.31
Working Capital	-10.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -446,969 and capital expenditures -1,647, giving a free cash flow of -448,616.

Operating Cash Flow	-446,969
Capital Expenditures	-1,647
Depreciation & Amortization	2,282
Net Borrowing	410,935
Free Cash Flow	-448,616
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross Margin	42.45%
Operating Margin	-134,646.70%
Pretax Margin	-267,469.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biosenta does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.41%
Shareholder Yield	-7.41%
Earnings Yield	-87.45%
FCF Yield	-15.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 28, 2016. It was a reverse split with a ratio of 0.0666666666.

Last Split Date	Jun 28, 2016
Split Type	Reverse
Split Ratio	0.0666666666

Scores

Biosenta has an Altman Z-Score of -576.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-576.9
Piotroski F-Score	2